"The development of the Natsimbio holding of the Rostec state corporation in the course of clinical trials has confirmed the effectiveness, safety and ability to neutralize the coronavirus," TASS said.
It is noted that the drug has received a permanent registration certificate from the Ministry of Health of Russia.
In September, it was reported that the drug "Covid Globulin" is undergoing the third stage of clinical trials.